Merck’s COVID-19 pill reduces hospitalization, death risk by 30%, company says

Posted by on November 26, 2021 7:31 am
Categories: Global Stories

The company said the data on the drug molnupiravir had been submitted to the U.S. Food and Drug Administration ahead of a meeting of its expert advisers on Tuesday.

Leave a Reply

Your email address will not be published.